EX-99.1 2 d677647dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement,

application for quotation of additional securities

and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005.

Name of entity

Immutep Limited (Company)

ABN

90 009 237 889

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

       1    +Class of +securities issued or to be issued    1.   

Ordinary Shares

 

     2.   

Ordinary Shares

 

     3.    Ordinary Shares
       2    Number of +securities issued or to be issued (if known) or maximum number which may be issued    1.   

16,666,667 Ordinary Shares

 

     2.   

2,500,000 Ordinary Shares

 

     3.    20,000,000 Ordinary Shares


       3    Principal terms of the +securities (e.g., if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)    1.   

Fully Paid Ordinary Shares

 

     2.   

Fully Paid Ordinary Shares

 

     3.   

Fully Paid Ordinary Shares

 

       
       
       
       4    Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?    1.   

‘Pari Pasu’ with existing Fully Paid Ordinary Shares

 

     2.   

‘Pari Pasu’ with existing Fully Paid Ordinary Shares

 

     3.    ‘Pari Pasu’ with existing Fully Paid Ordinary Shares
     If the additional securities do not rank equally, please state:      
        the date from which they do      
        the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment      
        the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment      
       5    Issue price or consideration    1.   

Nil.

 

     2.   

Nil.

 

     3.    Nil.
       6   

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

   1.   

Mr Marc Voigt exercises 2nd tranche of his performance rights which vested to him i.e. 16,666,667 to convert to ordinary shares, in accordance with shareholder approval received at the AGM on 17 November 2017.

 

     2.   

Dr Russell Howard exercises 1st tranche of his performance rights which vested to him i.e. 2,500,000 to convert to ordinary shares, in accordance with shareholder approval received at the AGM on 16 November 2018.

 

     3.    Vesting & exercise of Performance Rights under the Executive Incentive Plan into fully paid ordinary shares.

 

Immutep Limited, Level 12, 95 Pitt St, Sydney NSW 2000

Phone: +61 2 8315 7003 Fax: +61 2 8569 1880

ABN: 90 009 237 889


       6a   

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b – 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

   Yes
       6b    The date the security holder resolution under rule 7.1A was passed    16 November 2018
       6c    Number of +securities issued without security holder approval under rule 7.1    Nil
       6d    Number of +securities issued with security holder approval under rule 7.1A    Nil
       6e    Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)    1.   

16,666,667 ordinary shares are issued on exercise of 2nd tranche out of 50,000,000 performance rights approved for Mr Marc Voigt at the AGM on 17 November 2017.

 

     2.    2,500,000 ordinary shares are issued on exercise of 1st tranche out of 10,000,000 performance rights approved for Dr Russell Howard at the AGM on 16 November 2018.
       6f    Number of +securities issued under an exception in rule 7.2    3.    20,000,000 Ordinary Shares issued on exercising of performance rights
       6g    If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.    Not applicable
       6h    If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements    Not applicable

 

Immutep Limited, Level 12, 95 Pitt St, Sydney NSW 2000

Phone: +61 2 8315 7003 Fax: +61 2 8569 1880

ABN: 90 009 237 889


       6i    Calculate the entity’s remaining issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements    Refer Annexure 1
       7   

+Issue dates

 

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

 

Cross reference: item 33 of Appendix 3B.

 

   2 January, 2019
             

Number

  

+Class

       8     

Number and +class of all +securities quoted on ASX (including the securities in clause 2 if applicable)

 

   3,383,598,296    Ordinary fully paid shares (ASX: IMM)
             

Number

  

+Class - Options

       9      Number and +class of all (including the securities in clause 2 if applicable)   

Amount

  

Exercise Price        

  

Expiration Date

     371,445,231    $0.0237   

4 August 2020

 

     793,103    $0.057   

30 October 2020

 

     1,026,272    $0.040   

7 March 2021

 

     8,475,995    $0.025   

4 August 2025

 

          

Number

  

+Class - Warrants over NASDAQ listed American Depository Shares

          

Amount

  

Exercise Price        

  

Terms

           1,553,718    US$2.50   

Each Warrant entitles the holder to purchase 1 ADS (where one ADS = 100 Ordinary Shares) at the exercise price and is exercisable immediately. Each Warrant will expire 5 January 2023

 

 

Immutep Limited, Level 12, 95 Pitt St, Sydney NSW 2000

Phone: +61 2 8315 7003 Fax: +61 2 8569 1880

ABN: 90 009 237 889


           2,080,000    US$2.50   

Each Warrant entitles the holder to purchase 1 ADS (where one ADS = 100 Ordinary Shares) at the exercise price and is exercisable immediately. Each Warrant will expire on the third anniversary of the effective date of a registration statement covering resale of all of the warrant shares underlying the ADSs issuable upon exercise of the warrants.

 

          

Number

  

+Class - Performance Rights

          

Amount

  

Type        

  

Expiration Date

           5,472,734    NED PRs   

Each tranche of NED PRs will expire one year after Vesting Date if not exercised as indicated in the appendix 3B released on 6 December 2016.

 

           8,533,063    NED PRs   

Each tranche of NED PRs will expire one year after Vesting Date if not exercised as indicated in this appendix 3B released on 4 December 2017

 

           36,666,666    LTI   

Each tranche of LTIs will expire one year after Vesting Date if not exercised as indicated in this appendix 3B released on 4 December 2017

 

           10,000,000    LTI   

Each tranche of LTIs will expire one year after Vesting Date if not exercised as indicated in this appendix 3B released on 4 December 2017

 

           7,751,152    LTI   

Each tranche of LTIs will expire one year after Vesting Date if not exercised as indicated in this appendix 3B released on 2 October 2018

 

           7,500,000    NED PRs   

Each tranche of NED PRs will expire one year after Vesting Date if not exercised as indicated in the appendix 3B released on 21 November 2018.

 

 

Immutep Limited, Level 12, 95 Pitt St, Sydney NSW 2000

Phone: +61 2 8315 7003 Fax: +61 2 8569 1880

ABN: 90 009 237 889


          

Number

  

+Class - Convertible Notes

          

Amount

  

Type        

  

Expiration Date

           13,750,828    Convertible Notes each with a face value of AU$1, expiring on 4 August 2025

 

       10    Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)    Unchanged

Part 2 - Bonus issue or pro rata issue

 

       11   

Is security holder approval required?

 

   Not applicable
       12   

Is the issue renounceable or non-renounceable?

 

   Not applicable
       13   

Ratio in which the +securities will be offered

 

   Not applicable
       14   

+Class of +securities to which the offer relates

 

   Not applicable
       15   

+Record date to determine entitlements

 

   Not applicable
       16   

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

 

   Not applicable
       17   

Policy for deciding entitlements in relation to fractions

 

   Not applicable
       18   

Names of countries in which the entity has +security holders who will not be sent new issue documents

 

Note: Security holders must be told how their entitlements are to be dealt with.

 

Cross reference: rule 7.7.

 

   Not applicable
       19   

Closing date for receipt of acceptances or renunciations

 

   Not applicable

 

Immutep Limited, Level 12, 95 Pitt St, Sydney NSW 2000

Phone: +61 2 8315 7003 Fax: +61 2 8569 1880

ABN: 90 009 237 889


       20   

Names of any underwriters

 

   Not applicable
       21   

Amount of any underwriting fee or commission

 

   Not applicable
       22   

Names of any brokers to the issue

 

   Not applicable
       23   

Fee or commission payable to the broker to the issue

 

   Not applicable
       24   

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of +security holders

 

   Not applicable
       25   

If the issue is contingent on +security holders’ approval, the date of the meeting

 

   Not applicable
       26   

Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled

 

   Not applicable
       27   

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

 

   Not applicable
       28   

Date rights trading will begin (if applicable)

 

   Not applicable
       29   

Date rights trading will end (if applicable)

 

   Not applicable
       30   

How do +security holders sell their entitlements in full through a broker?

 

   Not applicable

 

Immutep Limited, Level 12, 95 Pitt St, Sydney NSW 2000

Phone: +61 2 8315 7003 Fax: +61 2 8569 1880

ABN: 90 009 237 889


       31   

How do +security holders sell part of their entitlements through a broker and accept for the balance?

 

   Not applicable
       32   

How do +security holders dispose of their entitlements (except by sale through a broker)?

 

   Not applicable
       33   

+Despatch date

 

   Not applicable

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

       34         

Type of securities

(tick one)

 

       (a)             

Securities described in Part 1

 

       (b)             

All other securities

 

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

 

       35             

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

 

       36             

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

 

 

Immutep Limited, Level 12, 95 Pitt St, Sydney NSW 2000

Phone: +61 2 8315 7003 Fax: +61 2 8569 1880

ABN: 90 009 237 889


       37             

A copy of any trust deed for the additional +securities

 

Entities that have ticked box 34(b)

 

       38         

Number of securities for which +quotation is sought

 

   Not applicable
       39         

Class of +securities for which quotation is sought

 

   Not applicable
       40         

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

 

   Not applicable
              

the date from which they do

 

     
              

the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

 

     
              

the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

 

     
       41         

Reason for request for quotation now

 

Example: In the case of restricted securities, end of restriction period

 

(if issued upon conversion of another security, clearly identify that other security)

 

   Not applicable

 

Immutep Limited, Level 12, 95 Pitt St, Sydney NSW 2000

Phone: +61 2 8315 7003 Fax: +61 2 8569 1880

ABN: 90 009 237 889


                

Number

  

+Class

       42         

Number and +class of all +securities quoted on ASX (including the securities in clause 38)

 

   Not applicable   

 

Immutep Limited, Level 12, 95 Pitt St, Sydney NSW 2000

Phone: +61 2 8315 7003 Fax: +61 2 8569 1880

ABN: 90 009 237 889


Quotation agreement

 

1

+Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2

We warrant the following to ASX.

 

   

The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

   

There is no reason why those +securities should not be granted +quotation.

 

   

An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

   

Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

   

If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3

We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4

We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

Sign here:   LOGO     Date: 2/1/2019
  Company secretary    
Print name:   Tom Bloomfield    

 

Immutep Limited, Level 12, 95 Pitt St, Sydney NSW 2000

Phone: +61 2 8315 7003 Fax: +61 2 8569 1880

ABN: 90 009 237 889


Appendix 3B – Annexure 1

Calculation of placement capacity under

rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

 

Rule 7.1 – Issues exceeding 15% of capital

 

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

 

Insert number of fully paid +ordinary securities on issue 12 months before the +issue date or date of agreement to issue

 

         2,399,329,199

Add the following:

 

   
        

Number of fully paid +ordinary securities issued in that 12 month period under an exception in rule 7.2

 

   
   

Number of fully paid +ordinary securities issued in that 12 month period with shareholder approval

 

    724,269,097
   

Number of partly paid +ordinary securities that became fully paid in that 12 month period

 

   

Note:

 

   
   

Include only ordinary securities here – other classes of equity securities cannot be added

 

   
   

Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

 

   
   

It may be useful to set out issues of securities on different dates as separate line items

 

   

Subtract the number of fully paid +ordinary securities cancelled during that 12 month period

 

    Nil
“A”     3,123,598,296

 

Immutep Limited, Level 12, 95 Pitt St, Sydney NSW 2000

Phone: +61 2 8315 7003 Fax: +61 2 8569 1880

ABN: 90 009 237 889


Step 2: Calculate 15% of “A”

 

“B”         

0.15

 

[Note: this value cannot be changed]

 

Multiply “A” by 0.15    

468,539,744

 

Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used

 

Insert number of +equity securities issued or agreed to be issued in that 12 month period not counting those issued:

 

    2,080,000 Warrants convertible into 2,080,000 ADS (representing 208,000,000 ordinary shares)
        

Under an exception in rule 7.2

 

   
        

Under rule 7.1A

 

   
        

With security holder approval under rule 7.1 or rule 7.4

 

   

Note:

 

   
        

This applies to equity securities, unless specifically excluded – not just ordinary securities

 

   
        

Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

 

   
        

It may be useful to set out issues of securities on different dates as separate line items

 

   
“C”         

208,000,000

 

Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1

 

“A” x 0.15

 

Note: number must be same as shown in Step 2

 

    468,539,744

Subtract “C”

 

Note: number must be same as shown in Step 3

 

    208,000,000

Total [“A” x 0.15] – “C”

 

 

   

260,539,744

 

Note: this is the remaining placement capacity under rule 7.1

 

 

Immutep Limited, Level 12, 95 Pitt St, Sydney NSW 2000

Phone: +61 2 8315 7003 Fax: +61 2 8569 1880

ABN: 90 009 237 889


Part 2

 

Rule 7.1A – Additional placement capacity for eligible entities

 

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

 

“A”

 

Note: number must be same as shown in Step 1 of Part 1

 

         3,123,598,296

Step 2: Calculate 10% of “A”

 

“D”         

0.10

 

Note: this value cannot be changed

 

Multiply “A” by 0.10

 

    312,359,829

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

 

Insert number of +equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

 

    260,000,000

Notes:

 

   
        

This applies to equity securities – not just ordinary securities

 

   
   

Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed

 

   
   

Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

 

   
   

It may be useful to set out issues of securities on different dates as separate line items

 

   

“E”

 

    260,000,000

 

Immutep Limited, Level 12, 95 Pitt St, Sydney NSW 2000

Phone: +61 2 8315 7003 Fax: +61 2 8569 1880

ABN: 90 009 237 889


Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

 

“A” x 0.10

 

Note: number must be same as shown in Step 2

 

         312,359,829

Subtract “E”

 

Note: number must be same as shown in Step 3

 

    260,000,000
Total [“A” x 0.10] – “E”    

52,359,829

 

Note: this is the remaining placement capacity under rule 7.1A

 

 

Immutep Limited, Level 12, 95 Pitt St, Sydney NSW 2000

Phone: +61 2 8315 7003 Fax: +61 2 8569 1880

ABN: 90 009 237 889